User profiles for "author:Michael S Conte"

Michael S. Conte

University of California
Verified email at ucsf.edu
Cited by 22280

[HTML][HTML] Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and …

MS Conte, FB Pomposelli, DG Clair, PJ Geraghty… - Journal of vascular …, 2015 - Elsevier
Peripheral arterial disease (PAD) continues to grow in global prevalence and consumes an
increasing amount of resources in the United States health care system. Overall rates of …

[HTML][HTML] Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia

MS Conte, PJ Geraghty, AW Bradbury… - Journal of vascular …, 2009 - Elsevier
OBJECTIVE: To develop a set of suggested objective performance goals (OPG) for
evaluating new catheter-based treatments in critical limb ischemia (CLI), based on evidence …

Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC)

MR Patel, MS Conte, DE Cutlip, N Dib… - Journal of the American …, 2015 - jacc.org
The lack of consistent definitions and nomenclature across clinical trials of novel devices,
drugs, or biologics poses a significant barrier to accrual of knowledge in and across …

[HTML][HTML] Global vascular guidelines on the management of chronic limb-threatening ischemia

MS Conte, AW Bradbury, P Kolh, JV White… - European Journal of …, 2019 - Elsevier
Guideline Summary Chronic limb-threatening ischemia (CLTI) is associated with mortality,
amputation, and impaired quality of life. These Global Vascular Guidelines (GVG) are …

[HTML][HTML] The society for vascular surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI)

JL Mills Sr, MS Conte, DG Armstrong… - Journal of vascular …, 2014 - Elsevier
Critical limb ischemia, first defined in 1982, was intended to delineate a subgroup of patients
with a threatened lower extremity primarily because of chronic ischemia. It was the intent of …

[HTML][HTML] Surgery or endovascular therapy for chronic limb-threatening ischemia

A Farber, MT Menard, MS Conte… - … England Journal of …, 2022 - Mass Medical Soc
Background Patients with chronic limb-threatening ischemia (CLTI) require revascularization
to improve limb perfusion and thereby limit the risk of amputation. It is uncertain whether an …

[HTML][HTML] Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery

MS Conte, DF Bandyk, AW Clowes, GL Moneta… - Journal of vascular …, 2006 - Elsevier
OBJECTIVE: The PREVENT III study was a prospective, randomized, double-blinded,
multicenter phase III trial of a novel molecular therapy (edifoligide; E2F decoy) for the …

[HTML][HTML] Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer

DG Armstrong, MA Swerdlow, AA Armstrong… - Journal of foot and ankle …, 2020 - Springer
Background In 2007, we reported a summary of data comparing diabetic foot complications
to cancer. The purpose of this brief report was to refresh this with the best available data as …

Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial

MJ Mann, AD Whittemore, MC Donaldson, M Belkin… - The Lancet, 1999 - thelancet.com
Background Cell-cycle blockade by ex-vivo gene therapy of experimental vein grafts inhibits
the neointimal hyperplasia and subsequent accelerated atherosclerosis that lead to human …

Acute limb ischemia

MA Creager, JA Kaufman… - New England Journal of …, 2012 - Mass Medical Soc
Key Clinical Points Acute Limb Ischemia Acute limb ischemia is a sudden decrease in limb
perfusion that threatens limb viability and requires urgent evaluation and management …